New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2014
07:19 EDTZMHZimmer Biomet deal very positive, says Bernstein
After Zimmer agreed to buy Biomet, Bernstein thinks the deal will be 17% accretive to cash EPS in the first year and 24% accretive in the second year. The firm expects Zimmer's stock to rise further as a result of the deal, and keeps an Outperform rating on the shares.
News For ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ZMH

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use